Sixteen members of the U.S. House of Representatives have sent a joint letter to Acting FDA...
Congressmen share our MOU concerns, support us with OMB
Seven members of Congress have written to OMB, sharing the same concerns we have about FDA's MOU on interstate shipments of compounded drugs: As written, it will place a tremendous and undue burden on state boards of pharmacy. Read the letter at https://a4pc.org/Common/Uploaded files/Advocacy/2020-06-08_Letter-to-OMB-on-MOU.pdf